Cytomegalovirus-positive Posner-Schlossman syndrome: to compare differences in retinal vessel area density between the affected and non-affected eye using optical coherence tomography angiography.

"Declarations Ethical approvalAll procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of the Charité–Universitätsmedizin Berlin (EA4/168/17) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Clinical trial registration was performed (website: https://www.drks.de/drks_web/, trial number: DRKS00028266). Informed consentInformed consent was obtained from all individual participants included in the study. Conflict of interestP.H. and E.R. report no financial interests. AR received speaking honoraria from Bayer Healthcare, Roche, and Novartis and served as a consultant for Novartis. AR receives research support from Deutsche Forschungsgemeinschaft (DFG) (RU 2020/3-1). A.-K. M. has served as a consultant for Allergan and Novartis. U.P. has served as a principal investigator or consultant for AbbVie, Alcon, Allergan, Alimera, Bayer, Dompé, Novartis, Santen, Shire, and Thea. Conflict of interest P.H. and E.R. report no financial interests. AR received speaking honoraria from Bayer Healthcare, Roche, and Novartis and served as a consultant for Novartis. AR receives research support from Deutsche Forschungsgemeinschaft (DFG) (RU 2020/3-1). A.-K. M. has served as a consultant for Allergan and Novartis. U.P. has served as a principal investigator or consultant for AbbVie, Alcon, Allergan, Alimera, Bayer, Dompé, Novartis, Santen, Shire, and Thea."

"Funding Open Access funding enabled and organized by Projekt DEAL."

"Trial registration TRN: DRKS00028266, https://www.drks.de/drks_web/."